Dr. Dennis Chi, MD

Claim this profile
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
1 reported clinical trial
1 drug studied

Area of expertise

1Ovarian Cancer
Dennis Chi, MD has run 1 trial for Ovarian Cancer. Some of their research focus areas include:
Stage IV
Stage III
2Fallopian Tube Cancer
Dennis Chi, MD has run 1 trial for Fallopian Tube Cancer. Some of their research focus areas include:
Stage IV
Stage III

Clinical Trials Dennis Chi, MD is currently running

More about Dennis Chi, MD

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Dennis Chi, MD has experience with
  • Acute Normovolemic Hemodilution/ANH
Breakdown of trials Dennis Chi, MD has run
Fallopian Tube Cancer

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dennis Chi, MD specialize in?
Dennis Chi, MD focuses on Ovarian Cancer and Fallopian Tube Cancer. In particular, much of their work with Ovarian Cancer has involved Stage IV patients, or patients who are Stage III.
Is Dennis Chi, MD currently recruiting for clinical trials?
Yes, Dennis Chi, MD is currently recruiting for 1 clinical trial in the USA. If you're interested in participating, you should apply.
Are there any treatments that Dennis Chi, MD has studied deeply?
Yes, Dennis Chi, MD has studied treatments such as Acute Normovolemic Hemodilution/ANH.
What is the best way to schedule an appointment with Dennis Chi, MD?
Apply for one of the trials that Dennis Chi, MD is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.